StockNews.com started coverage on shares of Global Cord Blood (NYSE:CO – Free Report) in a research note issued to investors on Saturday morning. The brokerage issued a strong-buy rating on the medical research company’s stock.
Global Cord Blood Stock Performance
NYSE:CO opened at $1.35 on Friday. The company has a 50-day moving average price of $1.50 and a 200-day moving average price of $1.36. Global Cord Blood has a 12 month low of $2.03 and a 12 month high of $5.50. The stock has a market cap of $164.09 million, a price-to-earnings ratio of 2.11 and a beta of 0.16.
About Global Cord Blood
Featured Stories
- Five stocks we like better than Global Cord Blood
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Charles Schwab Fortifies its Uptrend on EPS Beat
- What is Insider Trading? What You Can Learn from Insider Trading
- Lockheed Martin Stock Aims for a Fresh All-Time High
- What to Know About Investing in Penny Stocks
- Beyond the Halving: The Future of Bitcoin Mining Stocks
Receive News & Ratings for Global Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.